Longevity Health Holdings Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a XAGE research report →
Price Chart
About the company
Longevity Health Holdings Inc. specializes in creating plasma-based bioactive materials (PBMs) aimed at fostering tissue regeneration and repair in response to injury, illness, and the natural aging process. The company's primary investigational product is CT-101, which acts as a powerful accelerant for bone healing in diverse applications such as tibia fracture recovery, foot/ankle and spinal fusions, serving as a dental bone graft substitute, and filling bone voids.
- CEO
- Janakiram Ajjarapu
- IPO
- 2021
- Employees
- 10
- HQ
- Pittsburgh, PA, US
Get TickerSpark's AI analysis on XAGE
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $277.24K
- P/E
- -0.03
- PEG
- 0.00
- P/S
- 0.16
- P/B
- -0.03
- EV/EBITDA
- -0.10
- Div Yield
- 0.00%
- Gross Margin
- 54.63%
- Op Margin
- -357.55%
- Net Margin
- -404.84%
- ROE
- 107.36%
- ROIC
- 71.98%
Latest fiscal year · YoY change
- Revenue
- $1.91M+3701.4%
- Gross Profit
- $1.09M+2390.3%
- Op Income
- $-7,107,573
- Net Income
- $-6,905,282+33.4%
- EPS
- $-4.01-702.0%
- OCF Growth
- +24.1%
- FCF Growth
- +23.8%
- 52W High
- $0.56
- 52W Low
- $0.10
- 50D MA
- $0.13
- 200D MA
- $0.25
- Beta
- 0.45
- RSI (14)
- 43
- Avg Volume
- 1.61K
No earnings-call transcripts are available for XAGE yet.
- Free Float
- 65.6%
- Shares Outstanding
- 2.48M
- Float Shares
- 1.62M
of shares held by institutions
1 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Drw Securities, LLC | 14.15K | 0 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 16, 26 | Ajjarapu J. Ram | buy | 689,656 |
| Mar 16, 26 | Ajjarapu J. Ram | other | 0 |
| Oct 11, 24 | Bracken-Ferguson Kendra | other | 378,705 |
| Oct 11, 24 | Cassaday Bryan J. | other | 120,000 |
| Oct 11, 24 | Spenlehauer Gilles | other | 76,878 |
| Oct 11, 24 | Sturgeon Patrick A | other | 76,878 |
| Oct 11, 24 | Upton Richard A | other | 76,878 |
| Oct 11, 24 | Gregory Kathryn | other | 76,878 |
| Oct 11, 24 | Shukla Rajiv | other | 876,878 |
| Oct 11, 24 | Frisch Scott M. | other | 76,878 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our XAGE coverage
Recent articles, reports, and earnings notes.
No research on XAGE yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate XAGE report →Longevity Health Holdings Announces Exploration of Strategic Alternatives
globenewswire.com · Nov 11
Longevity Health Holdings Enters into Securities Purchase Agreement for Up to $625,000 in Gross Proceeds
globenewswire.com · Sep 8
Longevity Health Holdings Announces Settlement of Litigation with Puritan Partners LLC
globenewswire.com · Aug 17
Analyzing Longevity Health (NASDAQ:XAGE) and Spyglass Pharma (NASDAQ:SGP)
defenseworld.net · Apr 15
Head-To-Head Survey: MiniMed Group (NASDAQ:MMED) versus Longevity Health (NASDAQ:XAGE)
defenseworld.net · Apr 14
Head to Head Contrast: Longevity Health (NASDAQ:XAGE) & Biosig Technologies (NASDAQ:STEX)
defenseworld.net · Mar 27
Longevity Health Holdings Closes Strategic Investment and Appoints Ram Ajjarapu as Chairman and CEO to Drive Acquisition-Focused Growth
globenewswire.com · Mar 17
Longevity Health (NASDAQ:XAGE) and Spyglass Pharma (NASDAQ:SGP) Financial Comparison
defenseworld.net · Mar 14
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.